Novavax COVID-19 shot wins full license with tight age, risk restrictions from FDA

Novavax makes the nation's only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older

Novavax COVID-19 shot wins full license with tight age, risk restrictions from FDA
Novavax makes the nation's only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older